A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease.
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
It has been postulated that dehydroepiandrosterone (DHEA) and its sulfate ester, dehydroepiandrosterone sulfate (DHEAS), the major secretory products of the human adrenal gland, may be discriminators of life expectancy and aging. We examined the relation of base-line circulating DHEAS levels to subsequent 12-year mortality from any cause, from cardiovascular disease, and from ischemic heart disease in a population-based cohort of 242 men aged 50 to 79 years at the start of the study. Mean DHEAS levels decreased with age and were also significantly lower in men with a history of heart disease than in those without such a history. In men with no history of heart disease at base line, the age-adjusted relative risk associated with a DHEAS level below 140 micrograms per deciliter was 1.5 (P not significant) for death from any causes, 3.3 (P less than 0.05) for death from cardiovascular disease, and 3.2 (P less than 0.05) for death from ischemic heart disease. In multivariate analyses, an increase in DHEAS level of 100 micrograms per deciliter was associated with a 36 percent reduction in mortality from any causes (P less than 0.05) and a 48 percent reduction in mortality from cardiovascular disease (P less than 0.05), after adjustment for age, systolic blood pressure, serum cholesterol level, obesity, fasting plasma glucose level, cigarette smoking status, and personal history of heart disease. Our conclusions are limited by the single determination of DHEAS levels, but the data suggest that the DHEAS concentration is independently and inversely related to death from any cause and death from cardiovascular disease in men over age 50.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A large body of epidemiological data from crosssectional correlational studies has documented an association between the decline in DHEAS levels and various age-related disorders, including increased risk of cardiovascular events (3), malignancy (4), and osteoporosis (5).”
From Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial (2008) · cites this paper as [3]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
ORENTREICH, N., BRIND, J. L., RIZER, R. L., & VOGELMAN, J. H. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-551 · Cited by 1,349
CRIQUI, M. H., BARRETT-CONNOR, E., & AUSTIN, M. (1978) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112633 · Cited by 385
Self-citationEvidence for Adrenocortical Adaptation to Severe Illness*
PARKER, L. N., LEVIN, E. R., & LIFRAK, E. T. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-5-947 · Cited by 291
Prevention of obesity in Avy/a mice by dehydroepiandrosterone
Yen, T. T., Allan, J. A., Pearson, D. V., Action, J. M., & Greenberg, M. M. (1977) · Lipids · doi:10.1007/bf02533624 · Cited by 228
INHIBITION OF MAMMALIAN GLUCOSE-6-PHOSPHATE DEHYDROGENASE BY STEROIDS
Marks, P. A., & Banks, J. (1960) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.46.4.447 · Cited by 226
Schwartz, A. G. (1979) · PubMed · Cited by 218
THE SECRETION OF DEHYDROEPIANDROSTERONE AND DEHYDROEPIANDROSTERONE SULPHATE IN MAN
NIESCHLAG, E., LORIAUX, D. L., RUDER, H. J., ZUCKER, I. R., KIRSCHNER, M. A., & LIPSETT, M. B. (1973) · Journal of Endocrinology · doi:10.1677/joe.0.0570123 · Cited by 209
PAVLOV, E. P., HARMAN, S. M., CHROUSOS, G. P., LORIAUX, D. L., & BLACKMAN, M. R. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-4-767 · Cited by 188
ZUMOFF, B., ROSENFELD, R. S., STRAIN, G. W., LEVIN, J., & FUKUSHIMA, D. K. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-2-330 · Cited by 187
Research works printed but not linked: 7
- Vermeulen A. Adrenal androgens and aging. In: Genazzani AR, Thijssen JHH, Siiteri PK, eds. Adrenal androgens. New York: Raven Press, 1980:207–17.
- Lopez-S A. Metabolic and endocrine factors in aging. In: Rothschild H, Chapman CF, eds. Risk factors for senility. New York: Oxford University Press, 1984:205–19.
- Marmorston, 1957, Geriatrics, 12, 297
- Mantel, 1959, JNCI, 22, 719
- Šonka, 1964, J Physiol (Lond), 56, 650
- Schwartz, 1979, Cancer Res, 39, 1129
- Schwartz, 1985, Basic Life Sci, 35, 181
Cited by
Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study
Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J., & McKinlay, J. B. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)34871-1 · Cited by 5,074
Seeman, T. E. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440400111013 · Cited by 1,368
GRAY, A., FELDMAN, H. A., MCKINLAY, J. B., & LONGCOPE, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,118
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
Morales, A. J., Nolan, J. J., Nelson, J. C., & Yen, S. S. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.6.7515387 · Cited by 841
Self-citation
Metadata
- Authors
- Barrett-Connor, E., Khaw, K.-T., & Yen, S. S. C.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1986-12-11
- Volume
- 315
- Issue
- 24
- Pages
- 1519-1524
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2034566257
- Cited by
- 681
- References
- 36
- Citations by year
- 2025: 4 · 2024: 4 · 2023: 4 · 2022: 5 · 2021: 9 · 2020: 8 · 2019: 6 · 2018: 8 · 2017: 6 · 2016: 6 · 2015: 15 · 2014: 9 · 2013: 16 · 2012: 20
- FWCI
- 11.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01am031801-03)
- National Heart, Lung, and Blood Institute (HL 34591, HV-1-2160-L)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- dehydroepiandrosterone sulfate, mortality, cardiovascular disease, ischemic heart disease, aging, adrenal hormones, circulating hormone levels, men, life expectancy
- MeSH terms
- Aged, Aging, Analysis of Variance, Cardiovascular Diseases, Coronary Disease, Dehydroepiandrosterone, Humans, Life Expectancy, Male, Middle Aged, Mortality, Prospective Studies, Smoking, Dehydroepiandrosterone Sulfate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease. https://app.cochat.ai/papers/10.1056/nejm198612113152405
- The paper
- Barrett-Connor, E., Khaw, K.-T., & Yen, S. S. C. (1986). A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease. New England Journal of Medicine. https://doi.org/10.1056/nejm198612113152405
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.